Jain Global LLC Alkermes Plc. Transaction History
Jain Global LLC
- $7.88 Billion
- Q1 2025
A detailed history of Jain Global LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Jain Global LLC holds 30,078 shares of ALKS stock, worth $867,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,078
Previous 25,040
20.12%
Holding current value
$867,750
Previous $720 Million
99.86%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
409Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$840 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$525 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$340 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$231 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$199 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.74B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...